WeightWatchers has conducted a 6-month clinical trial of 180 participants on GLP-1 medication (Heinberg et al.), but the manuscript is under review and has not yet been published in a peer-reviewed journal
Join me for a powerful talk and Q&A, plus experience insights from 35 world-class speakers covering everything from nutrition and fitness to longevity and mental health
These powerful weight loss injections help regulate appetite, improve blood sugar control, and support long-term fat loss
Central control of energy balance by amylin and calcitonin receptor agonists and their potential for treatment of metabolic diseases
This transition, woven with clinical insights, requires a strategic approachstarting with a clean break from semaglutide, followed by a carefully calibrated introduction of tirzepatide
Bar plots showing Augur scores of hypothalamic non-neuronal cells from mice treated with the GIPR antagonist (f) , acyl-GLP-1 (g) , acyl-GIP (h) , or MAR709 (i)